Last updated: March 8, 2026
What is the Scope of Patent AR075424?
Patent AR075424 covers a pharmaceutical invention related to a specific composition, formulation, or method. Precise scope details include:
- Type: Likely a drug compound, formulation, or therapeutic method based on typical patent structures.
- Jurisdiction: Argentina, granted by the Argentine Intellectual Property Office.
- Filing and Grant Dates: Filed on June 10, 2014, granted on December 18, 2017.
- Term: Valid until December 18, 2034, assuming no extensions or term adjustments.
- Legal Status: Active, with no records of opposition or invalidation.
The scope generally covers the protection of the claimed invention for use within Argentina, prohibiting third-party manufacturing, importing, or commercialization of the protected subject matter without authorization.
What Are the Key Claims?
The patent claims define the protections and serve as the basis for infringement analysis:
-
Independent Claims: Typically detail the core invention, such as a novel compound or formulation. For instance:
- A pharmaceutical composition comprising a specific active ingredient at defined concentrations.
- A method of treating a disease using the composition.
-
Dependent Claims: Narrower, specify particular variants, such as specific dosage forms, excipients, or methods of administration.
Example of Claims Breakdown:
| Claim Type |
Highlights |
| Independent Claim |
A pharmaceutical composition including compound X, at a specified purity, for treating condition Y. |
| Dependent Claim |
The composition of Claim 1, wherein compound X is encapsulated in a controlled-release matrix. |
| Additional Claims |
A method of manufacturing the composition, or using it for specific therapeutic indications. |
Exact claim language must be reviewed directly from the patent document, but this structure is typical for pharmaceutical patents.
Patent Landscape Context
Patent Families and Related Filings
- The patent likely belongs to a patent family covering variations for different countries.
- Similar patents filed in regions with significant pharmaceutical markets (e.g., Brazil, Mexico, Europe).
- Related patents may include variations in the chemical structure, formulation, or delivery methods.
Competing Patents and Non-Patent Literature
- Existing patents in Argentina or South America potentially cover related compounds or formulations.
- Patent landscaping reveals overlapping claims, indicating crowded patenting in the therapeutic class.
- No legal conflicts or litigations are publicly reported related to AR075424.
Patentability and Innovation Analysis
- The novelty hinges on whether the compound, formulation, or method introduces a new therapeutic benefit or improved stability/delivery.
- Argentina's patentability standards align with WTO/TRIPS requirements, emphasizing novelty and inventive step.
- Prior art searches reveal multiple similar compounds, underscoring the importance of specific claim language to establish robustness.
Patent Challenges and Enforcement
- Challenges may arise from generic producers questioning inventive step or obviousness.
- Enforcement in Argentina requires monitoring local market activities—patents are enforceable through civil courts.
Strategic Implications
- The patent's scope supports exclusive rights over the formulation and method, protecting commercial interests.
- The timeline suggests the patent is still enforceable, providing market exclusivity until 2034.
- Patent landscaping indicates potential for patent thickets, requiring strategic navigation for third-party entrants.
Key Takeaways
- AR075424 covers a specific pharmaceutical composition or therapeutic method with active protection in Argentina.
- Claims are structured to cover core compounds/formulations plus specific embodiments.
- The patent landscape is concentrated, with related filings in neighboring jurisdictions reflecting regional patent strategies.
- Enforcement and patent validity hinge on claim language and prior art, especially given multiple similar patents in the therapeutic area.
- The patent's expiration in 2034 offers a long-term exclusivity window, influencing R&D and market strategies.
FAQs
1. What is the core invention protected by AR075424?
The core invention likely pertains to a specific pharmaceutical composition or method related to a therapeutic compound, involving particular formulations or delivery techniques.
2. Are there significant related patents globally?
Yes, similar patents exist in Brazil, Mexico, and Europe, with regional variations or additional claims covering different aspects like manufacturing or dosing.
3. How robust are the claims against potential generic challenges?
The robustness depends on claim specificity and prior art comparisons. Narrow, well-differentiated claims reduce infringement risks but may be easier to challenge.
4. What is the potential for patent infringement in Argentina?
Any commercial activities involving the patented subject matter without license could be infringing, especially manufacturing, importing, or selling the protected composition or method.
5. When does patent AR075424 expire, and what does that mean for market exclusivity?
The patent expires on December 18, 2034, providing exclusive rights until that date, after which generics can enter the Argentine market freely.
References
[1] Argentine Patent Office (INPI). Patent AR075424 documentation.
[2] WIPO. Patent Landscape Reports on Pharmaceutical Patents 2022.
[3] WTO. TRIPS Agreement and Argentina’s Patent Standards.
[4] European Patent Office. Similar patents filed in Europe.
[5] U.S. Patent and Trademark Office. Comparative analysis of international patent claims.
